Design and Sample Size Considerations for Simultaneous Global Drug Development Program
Authors:
- 1 September 2012
- journal article
- research article
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 22 (5) , 1060-1073
Abstract
Due to the potential impact of ethnic factors on clinical outcomes, the global registration of a new treatment is challenging. China and Japan often require local trials in addition to a multiregional clinical trial (MRCT) to support the efficacy and safety claim of the treatment. The impact of ethnic factors on the treatment effect has been intensively investigated and discussed from different perspectives. However, most current methods are focusing on the assessment of the consistency or similarity of the treatment effect between different ethnic groups in exploratory nature. In this article, we propose a new method for the design and sample size consideration for a simultaneous global drug development program (SGDDP) using weighted z-tests. In the proposed method, to test the efficacy of a new treatment for the targeted ethnic (TE) group, a weighted test that combines the information collected from both the TE group and the nontargeted ethnic (NTE) group is used. The influence of ethnic factors and local medical practice on the treatment effect is accounted for by down-weighting the information collected from NTE group in the combined test statistic. This design controls rigorously the overall false positive rate for the program at a given level. The sample sizes needed for the TE group in an SGDDP for three most commonly used efficacy endpoints, continuous, binary, and time-to-event, are then calculated.Keywords
This publication has 9 references indexed in Scilit:
- Sample size considerations for Japanese patients in a multi‐regional trial based on MHLW guidancePharmaceutical Statistics, 2010
- A Short Note on Sample Size EstimationStatistics in Biopharmaceutical Research, 2009
- Further Comments on the Alpha-Spending FunctionStatistics in Biosciences, 2009
- The Use of Weighted Z-Tests in Medical ResearchJournal of Biopharmaceutical Statistics, 2005
- A TWO-STAGE DESIGN FOR BRIDGING STUDIESJournal of Biopharmaceutical Statistics, 2004
- Increasing the sample size when the unblinded interim result is promisingStatistics in Medicine, 2004
- A Group Sequential Approach to Evaluation of Bridging StudiesJournal of Biopharmaceutical Statistics, 2003
- ASSESSING SENSITIVITY AND SIMILARITY IN BRIDGING STUDIESJournal of Biopharmaceutical Statistics, 2002
- Clinical Trials for Drug Registrations in Asian-Pacific Countries: Proposal for a New Paradigm from a Statistical PerspectiveControlled Clinical Trials, 2001